Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2023

May 5, 2023

35119_dirs_2023-05-05_179d0175-5e57-4c31-bdbe-2c2df983027c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2023-05-03

Reporting Person: Cote Timothy R. (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-03 Stock Option (Right to Buy) $1.42 A 15000 Acquired 2033-05-02 COMMON STOCK (15000) Direct